Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Zapater-Moros, Andrea"" wg kryterium: Autor


Tytuł :
Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancer
Autorzy :
Trilla-Fuertes, Lucía
Gámez-Pozo, AngeloAff1, Aff2
López-Camacho, Elena
Prado-Vázquez, Guillermo
Zapater-Moros, AndreaAff1, Aff2
López-Vacas, Rocío
Arevalillo, Jorge M.
Díaz-Almirón, Mariana
Navarro, Hilario
Maín, Paloma
Espinosa, EnriqueAff6, Aff7
Zamora, PilarAff6, Aff7
Fresno Vara, Juan ÁngelAff2, Aff7
Pokaż więcej
Źródło :
BMC Cancer. 20(1)
Czasopismo naukowe
Tytuł :
Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunities
Autorzy :
Trilla-Fuertes, Lucía
Gámez-Pozo, AngeloAff1, Aff2
Prado-Vázquez, Guillermo
Zapater-Moros, AndreaAff1, Aff2
Díaz-Almirón, Mariana
Arevalillo, Jorge M.
Ferrer-Gómez, María
Navarro, Hilario
Maín, Paloma
Espinosa, EnriqueAff6, Aff7
Pinto, ÁlvaroAff6, Aff7
Vara, Juan Ángel FresnoAff2, Aff7
Pokaż więcej
Źródło :
BMC Cancer. 19(1)
Czasopismo naukowe
Tytuł :
Melanoma proteomics suggests functional differences related to mutational status
Autorzy :
Trilla-Fuertes, Lucía
Gámez-Pozo, AngeloAff1, Aff2
Prado-Vázquez, GuillermoAff1, Aff2
Zapater-Moros, AndreaAff1, Aff2
Díaz-Almirón, Mariana
Fortes, Claudia
Ferrer-Gómez, María
López-Vacas, Rocío
Parra Blanco, Verónica
Márquez-Rodas, IvánAff6, Aff9
Soria, Ainara
Fresno Vara, Juan ÁngelAff2, Aff9
Espinosa, EnriqueAff8, Aff9
Pokaż więcej
Źródło :
Scientific Reports. 9(1)
Czasopismo naukowe
Tytuł :
Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer.
Autorzy :
L., Katerin Rojas
Trilla-Fuertes, Lucía
Gámez-Pozo, Angelo
Chiva, Cristina
Sepúlveda, Juan
Manso, Luis
Prado-Vázquez, Guillermo
Zapater-Moros, Andrea
López-Vacas, Rocío
Ferrer-Gómez, María
Mendiola, César
Espinosa, Enrique
Sabidó, Eduard
Ciruelos, Eva
Vara, Juan Ángel Fresno
Pokaż więcej
Źródło :
Ecancermedicalscience. 2019, Vol. 13 Issue 890-910, p1-9. 9p.
Czasopismo naukowe
Tytuł :
Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer.
Autorzy :
Rojas L K; Department of Medical Oncology, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.; Katerin L Rojas and Lucía Trilla-Fuertes contributed equally to this work.
Trilla-Fuertes L; Biomedica Molecular Medicine SL, 28049 Madrid, Spain.; Katerin L Rojas and Lucía Trilla-Fuertes contributed equally to this work.
Gámez-Pozo A; Biomedica Molecular Medicine SL, 28049 Madrid, Spain.; Molecular Oncology and Pathology Lab, Instituto de Genética Médica y Molecular-INGEMM, Hospital Universitario La Paz-IdiPAZ, 28029 Madrid, Spain.
Chiva C; Proteomics Unit, Center of Genomics Regulation, Barcelona Institute of Science and Technology, 08036 Barcelona, Spain.; Proteomics Unit, Universitat Pompeu Fabra, 08002 Barcelona, Spain.
Sepúlveda J; Department of Medical Oncology, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Manso L; Department of Medical Oncology, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Prado-Vázquez G; Biomedica Molecular Medicine SL, 28049 Madrid, Spain.; Molecular Oncology and Pathology Lab, Instituto de Genética Médica y Molecular-INGEMM, Hospital Universitario La Paz-IdiPAZ, 28029 Madrid, Spain.
Zapater-Moros A; Biomedica Molecular Medicine SL, 28049 Madrid, Spain.; Molecular Oncology and Pathology Lab, Instituto de Genética Médica y Molecular-INGEMM, Hospital Universitario La Paz-IdiPAZ, 28029 Madrid, Spain.
López-Vacas R; Molecular Oncology and Pathology Lab, Instituto de Genética Médica y Molecular-INGEMM, Hospital Universitario La Paz-IdiPAZ, 28029 Madrid, Spain.
Ferrer-Gómez M; Molecular Oncology and Pathology Lab, Instituto de Genética Médica y Molecular-INGEMM, Hospital Universitario La Paz-IdiPAZ, 28029 Madrid, Spain.
Mendiola C; Department of Medical Oncology, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Espinosa E; Medical Oncology Service, Hospital Universitario La Paz-IdiPAZ, 28029 Madrid, Spain.; CIBERONC, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Sabidó E; Proteomics Unit, Center of Genomics Regulation, Barcelona Institute of Science and Technology, 08036 Barcelona, Spain.; Proteomics Unit, Universitat Pompeu Fabra, 08002 Barcelona, Spain.
Ciruelos E; Department of Medical Oncology, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Vara JÁF; Biomedica Molecular Medicine SL, 28049 Madrid, Spain.; Molecular Oncology and Pathology Lab, Instituto de Genética Médica y Molecular-INGEMM, Hospital Universitario La Paz-IdiPAZ, 28029 Madrid, Spain.; CIBERONC, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Pokaż więcej
Źródło :
Ecancermedicalscience [Ecancermedicalscience] 2019 Jan 15; Vol. 13, pp. 891. Date of Electronic Publication: 2019 Jan 15 (Print Publication: 2019).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in breast cancer.
Autorzy :
Zapater-Moros A; Molecular Oncology & Pathology Laboratory, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain.
Gámez-Pozo A; Molecular Oncology & Pathology Laboratory, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain.; Biomedica Molecular Medicine SL, Madrid, Spain.
Prado-Vázquez G; Molecular Oncology & Pathology Laboratory, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain.
Trilla-Fuertes L; Biomedica Molecular Medicine SL, Madrid, Spain.
Arevalillo JM; Operational Research and Numerical Analysis, National Distance Education University, Madrid, Spain.
Díaz-Almirón M; Biostatistics Unit, La Paz University Hospital-IdiPAZ, Madrid, Spain.
Navarro H; Operational Research and Numerical Analysis, National Distance Education University, Madrid, Spain.
Maín P; Department of Statistics and Operations Research, Faculty of Mathematics, Complutense University of Madrid, Madrid, Spain.
Feliú J; Medical Oncology Service, La Paz University Hospital-IdiPAZ, Madrid, Spain.; CIBERONC, Madrid, Spain.
Zamora P; Medical Oncology Service, La Paz University Hospital-IdiPAZ, Madrid, Spain.
Espinosa E; Medical Oncology Service, La Paz University Hospital-IdiPAZ, Madrid, Spain.; CIBERONC, Madrid, Spain.
Fresno Vara JÁ; Molecular Oncology & Pathology Laboratory, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain.; Biomedica Molecular Medicine SL, Madrid, Spain.; CIBERONC, Madrid, Spain.
Pokaż więcej
Źródło :
Oncotarget [Oncotarget] 2018 Jun 12; Vol. 9 (45), pp. 27586-27594. Date of Electronic Publication: 2018 Jun 12 (Print Publication: 2018).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Molecular characterization of breast cancer cell response to metabolic drugs.
Autorzy :
Trilla-Fuertes L; Molecular Oncology and Pathology Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain.; Biomedica Molecular Medicine SL, Madrid, Spain.
Gámez-Pozo A; Molecular Oncology and Pathology Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain.; Biomedica Molecular Medicine SL, Madrid, Spain.
Arevalillo JM; Operational Research and Numerical Analysis, National Distance Education University (UNED), Madrid, Spain.
Díaz-Almirón M; Biostatistics Unit, La Paz University Hospital-IdiPAZ, Madrid, Spain.
Prado-Vázquez G; Molecular Oncology and Pathology Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain.
Zapater-Moros A; Molecular Oncology and Pathology Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain.
Navarro H; Operational Research and Numerical Analysis, National Distance Education University (UNED), Madrid, Spain.
Aras-López R; Congenital Malformations Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital, IdiPAZ, Madrid, Spain.
Dapía I; Pharmacogenetics Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Autonomous University of Madrid, Madrid, Spain.; Biomedical Research Networking Center on Rare Diseases-CIBERER, ISCIII, Madrid, Spain.
López-Vacas R; Molecular Oncology and Pathology Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain.
Nanni P; Functional Genomics Center Zurich, University of Zurich/ETH Zurich, Zurich, Switzerland.
Llorente-Armijo S; Molecular Oncology and Pathology Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain.
Arias P; Pharmacogenetics Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Autonomous University of Madrid, Madrid, Spain.; Biomedical Research Networking Center on Rare Diseases-CIBERER, ISCIII, Madrid, Spain.
Borobia AM; Clinical Pharmacology Department, La Paz University Hospital School of Medicine, IdiPAZ, Autonomous University of Madrid, Madrid, Spain.
Maín P; Department of Statistics and Operations Research, Faculty of Mathematics, Complutense University of Madrid, Madrid, Spain.
Feliú J; Medical Oncology Service, La Paz University Hospital-IdiPAZ, Madrid, Spain.; Biomedical Research Networking Center on Oncology-CIBERONC, ISCIII, Madrid, Spain.; Cátedra UAM-AMGEN, Universidad Autónoma de Madrid, Madrid, Spain.
Espinosa E; Medical Oncology Service, La Paz University Hospital-IdiPAZ, Madrid, Spain.; Biomedical Research Networking Center on Oncology-CIBERONC, ISCIII, Madrid, Spain.
Fresno Vara JÁ; Molecular Oncology and Pathology Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain.; Biomedica Molecular Medicine SL, Madrid, Spain.; Biomedical Research Networking Center on Oncology-CIBERONC, ISCIII, Madrid, Spain.
Pokaż więcej
Źródło :
Oncotarget [Oncotarget] 2018 Jan 08; Vol. 9 (11), pp. 9645-9660. Date of Electronic Publication: 2018 Jan 08 (Print Publication: 2018).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Functional proteomics outlines the complexity of breast cancer molecular subtypes.
Autorzy :
Gámez-Pozo A; Molecular Oncology & Pathology Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain.
Trilla-Fuertes L; Biomedica Molecular Medicine SL, Madrid, Spain.
Berges-Soria J; Molecular Oncology & Pathology Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain.
Selevsek N; Functional Genomics Center Zürich, University of Zürich/ETH Zürich, Zürich, Switzerland.
López-Vacas R; Molecular Oncology & Pathology Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain.
Díaz-Almirón M; Department of Statistics, Biostatistics Unit, La Paz University Hospital - IdiPAZ, Madrid, Spain.
Nanni P; Functional Genomics Center Zürich, University of Zürich/ETH Zürich, Zürich, Switzerland.
Arevalillo JM; Operational Research and Numerical Analysis, National Distance Education University (UNED), Madrid, Spain.
Navarro H; Operational Research and Numerical Analysis, National Distance Education University (UNED), Madrid, Spain.
Grossmann J; Functional Genomics Center Zürich, University of Zürich/ETH Zürich, Zürich, Switzerland.
Gayá Moreno F; Department of Statistics, Biostatistics Unit, La Paz University Hospital - IdiPAZ, Madrid, Spain.
Gómez Rioja R; Medical Laboratory Service, La Paz University Hospital Health Research Institute-IdiPAZ, Madrid, Spain.
Prado-Vázquez G; Molecular Oncology & Pathology Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain.
Zapater-Moros A; Molecular Oncology & Pathology Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain.
Main P; Department of Statistics and Operations Research, Faculty of Mathematics, Complutense University of Madrid, Madrid, Spain.
Feliú J; Medical Oncology Service, La Paz University Hospital-IdiPAZ, Madrid, Spain.
Martínez Del Prado P; Medical Oncology Service, Basurto Hospital, Bilbao, Spain.
Zamora P; Medical Oncology Service, La Paz University Hospital-IdiPAZ, Madrid, Spain.
Ciruelos E; Medical Oncology Service, Hospital 12 de Octubre (i+12) Health Research Institute, Madrid, Spain.
Espinosa E; Medical Oncology Service, La Paz University Hospital-IdiPAZ, Madrid, Spain.
Fresno Vara JÁ; Molecular Oncology & Pathology Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2017 Aug 30; Vol. 7 (1), pp. 10100. Date of Electronic Publication: 2017 Aug 30.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Proteomics*
Breast Neoplasms/*genetics
Breast Neoplasms/classification ; Breast Neoplasms/pathology ; Disease-Free Survival ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; MicroRNAs/genetics ; Phenotype ; Prognosis ; Receptors, Estrogen/genetics ; Receptors, Progesterone/genetics ; Triple Negative Breast Neoplasms/genetics ; Triple Negative Breast Neoplasms/pathology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies